Sat, Oct 25, 2014, 6:20 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

  • chimakot chimakot Jul 12, 2013 8:12 AM Flag

    I like this recap from the Mad Money interview.

    Simple and to the point.

    CEO Interview: Jeff Stein, Trius Therapeutics (TSRX)

    Trius Therapeutics (TSRX) is a speculative biotech company focusing on treating drug resistant bacteria. Its lead product to treat skin infections could get approval by 2014, and may potentially be a billion dollar drug. The stocks has doubled since the beginning of the year. Cramer recommended buying it then selling it because it had gotten "too hot," but it has rallied over a dollar since. For those who want to buy TSRX, Cramer recommended using limit orders. CEO Jeff Stein is optimistic the FDA will approve its drugs because of the growing problem of "superbugs" that are resistant to other forms of antibiotics. "This is a hot stock," Cramer said, "but they are doing what the FDA wants them to do."

    Let's Ride!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
TSRX
13.630.00(0.00%)Sep 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.